Cathie Wood does something most money managers don’t: she publishes every ETF trade at the close of each trading day. Wednesday’s disclosures showed Ark Invest adding to existing positions in three stocks that have fallen hard over the past year, with losses ranging from single digits to nearly 80%.
Buying what the market has soured on is a familiar Wood move. The three names below are all dealing with slowing growth or unfinished business, and each has a case that the selling has gone too far.
Netflix (NFLX): A Two-Year Low for the Streaming Leader
Netflix hit a two-year low on Wednesday after issuing fourth-quarter guidance that disappointed. The 11.5% revenue growth it is targeting would be its weakest showing in more than three years, and it comes despite price increases in the U.S. and other markets earlier this year and a continued push into ad-supported tiers. Ad revenue, which was meant to be a meaningful addition to subscription income, still makes up only about 5% of the business, and the company lowered its ad projection for the year. A 6% workforce reduction earlier this month and a couple of high-profile departures added to the unease.
The stock trades around $67 and has lost roughly 40% of its value over the past year, giving it a market cap near $271 billion. The business itself still looks sturdy. Netflix has more than 300 million members worldwide and posted double-digit revenue growth in all four of its geographic regions. At about 17 times next year’s earnings estimates, it is priced well below where it has been, and it remains the dominant player in premium streaming. Profit targets may drift lower in the near term, but a scalable leader in an expanding industry has a record of working out over time.
Oklo (OKLO): From Market Darling to a Long Wait
Oklo was one of the hottest stocks of 2025, rising ninefold by the time it peaked in October of last year. It has since surrendered about 86% of its value, and shares now trade around $27. The appeal was its fast-fission and nuclear recycling technology at a moment when AI investors were looking for clean power for data centers. The catch is that Oklo was only getting started on deployment.
Revenue only began this year and isn’t expected to top $10 million next year, with profitability at least five years away. Analysts do see revenue reaching $312 million by 2030, and demand for efficient, cleaner power to feed AI workloads is real. Even at a market cap of about $5.2 billion, nearly half of that value is backed by the company’s cash-rich balance sheet. The technology remains promising, but shareholders should expect the stock to stay volatile.
Intuitive Surgical (ISRG): Slowing Growth, Sticky Platform
Intuitive Surgical has the mildest one-year chart of the three, down about 7% over the past year, though shares have lost nearly a quarter of their value in 2026. The maker of the da Vinci robotic surgery platform opened the year on track for a fourth straight year of accelerating growth. Analysts now expect revenue growth to slow to 13% this quarter, the weakest in nearly three years, with further deceleration expected in 2027.
Competition for da Vinci is emerging, which is part of why the stock has struggled. Still, earnings estimates keep inching higher, and the company has posted double-digit-percentage bottom-line beats consistently over the past year. Surgeons and hospitals face a real learning curve and switching costs in moving away from a proven platform, and that stickiness is the core of the argument that bears are underestimating the business. The shares trade around $441, with a market cap of roughly $151 billion.
